Vaccine makers see off push to share Covid know-how

Opposing the sharing of its intellectual property, the company’s board argued that “vaccine manufacturing is a biological production that is extraordinarily complex”, involving 280 ingredients from 86 suppliers in 19 countries. They added there was a risk to patients if other manufacturers were not able to meet all the requirements to make its vaccines properly.

Recent Posts

Will Nadhim Zahawi change tack on the economy?

He acknowledged both he and the prime minister wanted a "low-tax, high-growth economy, and world class public services", but Mr Sunak said this could only be "responsibly delivered if we are prepared to work hard, make sacrifices and take difficult decisions".

read more

Pound slides to two-year low against the dollar

George Godber, a fund manager with Polar Capital, said gas prices were set to rise even further later in the year: "Our companies are struggling with this deteriorating economic outlook. How do businesses and consumers plan for rising gas prices, and the squeeze in...

read more

What does egg freezing have to do with your employer?

"I didn't meet my man in college, didn't meet my man in law school," she explains, "so there is this sense in the back of your head that you need to hurry up and just have a kid. I'm OK with the commodification of it, especially in America, as we're having to revisit...

read more